News

A new study published in the Journal of Neuroscience revealed that specific immune cells and degradation of a nutrient called arginine might be linked to Alzheimer’s disease development. The study was performed by researchers at Duke University Medical Center, the West Virginia University School…

Last year, as part of a large nationwide study, Scott Turner, MD, PhD., neurologist at Georgetown University, began to enroll participants with mild to moderate Alzheimer’s disease and found that a major part of the study participants had undiagnosed glucose intolerance. As Dr. Turner said in a recent news release, he…

Over the last five years, Project Lifesaver International has expanded its program to new territories across the United States. The expansion was possible thanks to a Federal grant from the Bureau of Justice Assistance (BJA) under the Missing Alzheimer’s Patient Assistance program. This grant has helped fund over 205 Project Lifesaver public safety agencies since 2010.

A new study, entitled Anti-Amyloid in Asymptomatic Alzheimer’s study, simply referred to as the A4 study, is currently recruiting African-American volunteers that have already developed brain alterations as a result of Alzheimer’s disease but that have not yet developed symptoms. The study aims to decrease the progression of Alzheimer’s-induced brain…

The Harvard College Alzheimer’s Buddies (HCAB) student association is organizing an interdisciplinary symposium to encourage discussion and debate among students on the complexity of Alzheimer’s disease. The Alzheimer’s Symposium, which is open not only for students, but for anyone interested in participating, is taking place on April 18th in Cambridge, MA. The…

Evidence indicates that low-frequency alternating magnetic fields generated by overhead power lines aggravate neurodegenerative disorders including Alzheimer’s disease and amyotrophic lateral sclerosis (ALS). Nevertheless, recent research conducted by scientists from the Institute of Pathobiochemistry at the Medical Center of Johannes Gutenberg University Mainz (JGU) in Germany found no evidence…

A new study led by a team of researchers at the Icahn School of Medicine at Mount Sinai Hospital in New York recently revealed that compounds called glycotoxins found in over-cooked foods may increase the risk for age-related dementia, with Alzheimer’s disease the most common type of dementia. The study is…

Dr. Anuradha Kalani from the University of Louisville in Kentucky and colleagues recently presented at the Experimental Biology Annual Meeting in Boston the finding that a diet rich in methionine can increase the risk of memory loss. Methionine is an essential amino acid important for several cellular functions…

Decreasing aggregates of amyloid beta peptide (Aβ) is the most common strategy for treating Alzheimer’s disease. One treatment that is undergoing phase 3 clinical trials is beta site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors, which are predicted to decrease the production of Aβ and prevent neurotoxic fibril and…

Researchers at Yale University School of Medicine in New Haven recently published in the journal Annals of Neurology the finding that a specific experimental anti-cancer drug can be used as an effective therapy for Alzheimer’s disease. The study is entitled “Fyn inhibition…